×
×

Blog: Sleep & Respiratory Healthcare

press release
CareFusion NOX-T3 Monitor Integration


Integration with CareFusion NOX-T3 portable sleep monitor enables Somnoware users to more easily score, review, report, and export sleep study data.

020.jpgSomnoware, a leading provider of digital health technology, announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a sleep device integration plugin that provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing devices and importing studies are just one-click operations. 

This plugin streamlines the user experience when conducting home sleep studies and allows for automated home sleep testing (HST) device inventory management. After a sleep study is completed, the plugin automatically uploads study data to the Somnoware cloud and the device becomes available for the next patient. The study import operation is automatic without requiring any user input or barcode scanning, minimizing potential typing and device assignment errors. When a report is ready for interpretation, the physician receives an email notification.

By having access to the Somnoware platform, sleep center staff can easily schedule in-lab and home tests across various facilities, as well as quickly configure sleep devices and track inventory. Physicians also have easy access to test results and CPAP adherence data via the web browser. They can read the diagnosis and titration reports, and implement strategies for increasing therapy adherence. The overall use of this platform results in a significant reduction in interpretation times and enables better patient care.

“We are very excited about the integration of CareFusion NOX-T3 with Somnoware. This integration significantly augments the Noxturnal user experience by delivering automation to increase sleep center efficiency and lower error rates,” according to Jinesh Jain, Director of Clinical Technology at Somnoware.

Disclaimer: CareFusion and NOX-T3 are registered trademarks of BD in all countries. Noxturnal Software System is a registered trademark of Nox Medical in all countries. All other product and company names are trademarks or registered trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.


About Somnoware

Somnoware is transforming respiratory healthcare by reducing cost and improving care management. Our cloud-based software enables care providers to estimate population risk, automate diagnosis workflow, better manage chronic care, and optimize patient outcomes. We provide unique insights by driving interoperability and applying patented artificial intelligence algorithms to patient data integrated from hundreds of sources. Headquartered in Sunnyvale, California, our customer base includes leading healthcare systems, accountable care organizations, independent test labs, and service companies. For more information, please visit www.somnoware.com or follow us on twitter @somnoware.

The company offers the industry’s leading respiratory healthcare management platform that integrates with over 150 software systems and devices. The platform is currently used by one in five pulmonologists in the United States. Physicians get instant access to diagnostic test data, e-signature capability, one-click DME ordering, PAP compliance data, and the ability to conduct end-to-end patient care management. Diagnostic test centers can automate their complete workflow including scheduling at multiple centers, inventory management, automated reporting, therapy ordering, and accreditation. Using Somnoware, customers are able to reduce time to diagnosis by up to 80% resulting in significant reduction in cost of care and increased provider capacity.

To learn more about Somnoware, please contact Raj Misra at media(at)somnoware(dot)com.




Topics: Sleep Data, Value Based Care, sleep data, Sleep Practice Management, Sleep Medicine, sleep software, Sleep Wellness, pinned, press release

Share

Related Articles